Israeli medical company Dune Medical Devices inc., has received FDA approval for its MarginProbe device, which improves results of tumor removal in breast cancer patients. Dune Medical, which was founded in 2004, has raised $30 to date and says it will continue developing other devices for the medical market.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israel's Top Hospital Unveils Program To Promote HealthTech Startups
September 12, 2024
Battery Startup Announces Superfast Charging For Electric Vehicles
September 12, 2024
Automated Marketing Firm Unveils New Image Editing Suite
September 11, 2024
Israeli Renewable Energy Firm Launches First US Solar Power Project
September 11, 2024
Facebook comments